E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/2/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: CepTor negotiates offering of convertibles for up to $6 million

By Sheri Kasprzak

New York, June 2 - CepTor, Inc. said it plans to raise up to $6 million and at least $1.5 million from a private placement of convertible notes.

The one-year notes bear interest at 6% annually and are convertible into common shares at $0.15 each.

Brookshire Securities Corp. is the placement agent.

The placement is expected to close June 30, but the offering may be extended.

CepTor, located in Hunt Valley, Md., is a development-stage biopharmaceutical company engaged in the development of cell-targeted therapeutics for the treatment of neuromuscular and neurodegenerative diseases with a focus on orphan diseases.

Issuer:CepTor, Inc.
Issue:Convertible notes
Amount:$6 million
Maturity:One year
Coupon:6%
Price:Par
Yield:6%
Conversion price:$0.15
Warrants:No
Placement agent:Brookshire Securities Corp.
Pricing date:May 26
Settlement date:June 30, unless extended
Stock symbol:OTCBB: CEPO
Stock price:$0.18 at close May 26

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.